Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0000950170-25-046742)

Filing Details

Accession Number:: 0000950170-25-046742
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2025-03-28 16:00:03
Reporting Period:: 2025-03-26

Filing Date:: 2025-03-28
Accepted Time:: 2025-03-28 16:00:03
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1488039	Atossa Therapeutics Inc.	ATOS	Pharmaceutical Preparations (2834)	264753208

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1551817	Lawrence H. Remmel	C/O Atossa Therapeutics, Inc., 10202 5Th Ave Ne, Suite 200 Seattle WA 98125		No	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2025-03-26	10,000	$0.70	10,257	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Footnotes

Reflects a reverse stock split of the Issuer's common stock at a ratio of 12:1 effective April 2018. The Reporting Person disclaims beneficial ownership of 11 shares of common stock owned by his spouse except to the extent of his pecuniary interest in the shares.